MENU
PJP
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

PJP stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for PJP with price predictions
Nov 06, 2026

PJP's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PJP turned positive on October 15, 2026. Looking at past instances where PJP's MACD turned positive, the stock continued to rise in 42 of 47 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on PJP as a result. In 72 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

PJP moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PJP crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

Following a +3.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where PJP advanced for three days, in 259 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

The Aroon Indicator entered an Uptrend today. In 239 of 287 cases where PJP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 67 cases where PJP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PJP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

PJP broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Pharmaceuticals ETF (PJP) ETF is 135.17B. The market cap for tickers in the group ranges from 788.17M to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is COLL at 788.17M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Pharmaceuticals ETF (PJP) ETF was 15%. For the same ETF, the average monthly price growth was 75%, and the average quarterly price growth was 70%. JAZZ experienced the highest price growth at 9%, while HRMY experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Invesco Pharmaceuticals ETF (PJP) ETF was -4%. For the same stocks of the ETF, the average monthly volume growth was 33% and the average quarterly volume growth was -8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 50
Price Growth Rating: 38
SMR Rating: 63
Profit Risk Rating: 52
Seasonality Score: 14 (-100 ... +100)
PJP's MACD Histogram just turned positive